These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 37934373)
1. Prognostic potential of circulating cell free mitochondrial DNA levels in COVID-19 patients. Mahmoodpoor A; Mohammadzadeh M; Asghari R; Tagizadeh M; Iranpour A; Rezayi M; Pahnvar AJ; Emamalizadeh B; Sohrabifar N; Kazeminasab S Mol Biol Rep; 2023 Dec; 50(12):10249-10255. PubMed ID: 37934373 [TBL] [Abstract][Full Text] [Related]
2. Roles of mitochondrial DNA in dynamics of the immune response to COVID-19. Mahmoodpoor A; Sanaie S; Ostadi Z; Eskandari M; Behrouzi N; Asghari R; Zahirnia A; Sohrabifar N; Kazeminasab S Gene; 2022 Aug; 836():146681. PubMed ID: 35728769 [TBL] [Abstract][Full Text] [Related]
3. Accurate quantitation of circulating cell-free mitochondrial DNA in plasma by droplet digital PCR. Ye W; Tang X; Liu C; Wen C; Li W; Lyu J Anal Bioanal Chem; 2017 Apr; 409(10):2727-2735. PubMed ID: 28154880 [TBL] [Abstract][Full Text] [Related]
4. Reduced Maternal Circulating Cell-Free Mitochondrial DNA Is Associated With the Development of Preeclampsia. Cushen SC; Ricci CA; Bradshaw JL; Silzer T; Blessing A; Sun J; Zhou Z; Scroggins SM; Santillan MK; Santillan DA; Phillips NR; Goulopoulou S J Am Heart Assoc; 2022 Jan; 11(2):e021726. PubMed ID: 35014857 [TBL] [Abstract][Full Text] [Related]
7. Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson's Disease Patients. Wojtkowska M; Karczewska N; Pacewicz K; Pacak A; Kopeć P; Florczak-Wyspiańska J; Popławska-Domaszewicz K; Małkiewicz T; Sokół B Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474065 [TBL] [Abstract][Full Text] [Related]
8. Effects of caloric restriction and aerobic exercise on circulating cell-free mitochondrial DNA in patients with moderate to severe chronic kidney disease. Jaramillo-Morales J; Korucu B; Pike MM; Lipworth L; Stewart T; Headley SAE; Germain M; Begue G; Roshanravan B; Tuttle KR; Himmelfarb J; Robinson-Cohen C; Ikizler TA; Gamboa JL Am J Physiol Renal Physiol; 2022 Jan; 322(1):F68-F75. PubMed ID: 34843657 [TBL] [Abstract][Full Text] [Related]
9. An automated, high-throughput methodology optimized for quantitative cell-free mitochondrial and nuclear DNA isolation from plasma. Ware SA; Desai N; Lopez M; Leach D; Zhang Y; Giordano L; Nouraie M; Picard M; Kaufman BA J Biol Chem; 2020 Nov; 295(46):15677-15691. PubMed ID: 32900851 [TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free mitochondrial DNA in brain health and disease: A systematic review and meta-analysis. Park SS; Jeong H; Andreazza AC World J Biol Psychiatry; 2022 Feb; 23(2):87-102. PubMed ID: 34096821 [TBL] [Abstract][Full Text] [Related]
11. Predictors of ccf-mtDNA reactivity to acute psychological stress identified using machine learning classifiers: A proof-of-concept. Trumpff C; Marsland AL; Sloan RP; Kaufman BA; Picard M Psychoneuroendocrinology; 2019 Sep; 107():82-92. PubMed ID: 31112904 [TBL] [Abstract][Full Text] [Related]
12. A Method for Evaluation of the Level of Circulating Mitochondrial DNA by ND1 and ND2 Genes. Ogarkov OB; Orlova EA; Malov IV; Zhdanova SN; Malov SI; Khromova PA; Stepanenko LA; Sinkov VV; Rychkova LV; Kolesnikova LI Bull Exp Biol Med; 2022 Feb; 172(4):495-498. PubMed ID: 35175481 [TBL] [Abstract][Full Text] [Related]
13. Increased Levels of Circulating Cell-Free mtDNA in the Plasma of Subjects With Late-Life Depression and Frailty: A Preliminary Study. Ampo E; Mendes-Silva AP; Goncalves V; Bartley JM; Kuchel GA; Diniz BS Am J Geriatr Psychiatry; 2022 Mar; 30(3):332-337. PubMed ID: 34412934 [TBL] [Abstract][Full Text] [Related]
14. Altered levels of circulating mitochondrial DNA in elderly people with sarcopenia: Association with mitochondrial impairment. Fan Z; Yang JY; Guo Y; Liu YX; Zhong XY Exp Gerontol; 2022 Jun; 163():111802. PubMed ID: 35398474 [TBL] [Abstract][Full Text] [Related]
15. Fragmentomics of plasma mitochondrial and nuclear DNA inform prognosis in COVID-19 patients with critical symptoms. Zhang H; Li L; Luo Y; Zheng F; Zhang Y; Xie R; Ou R; Chen Y; Lin Y; Wang Y; Jin Y; Xu J; Tao Y; Qu R; Zhou W; Bai Y; Cheng F; Jin X BMC Med Genomics; 2024 Oct; 17(1):243. PubMed ID: 39363185 [TBL] [Abstract][Full Text] [Related]
16. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. Scozzi D; Cano M; Ma L; Zhou D; Zhu JH; O'Halloran JA; Goss C; Rauseo AM; Liu Z; Sahu SK; Peritore V; Rocco M; Ricci A; Amodeo R; Aimati L; Ibrahim M; Hachem R; Kreisel D; Mudd PA; Kulkarni HS; Gelman AE JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33444289 [TBL] [Abstract][Full Text] [Related]
17. Circulating Cell-Free Mitochondrial DNA in Pregnancy. Bradshaw JL; Cushen SC; Phillips NR; Goulopoulou S Physiology (Bethesda); 2022 Jul; 37(4):0. PubMed ID: 35001655 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Costa TJ; Potje SR; Fraga-Silva TFC; da Silva-Neto JA; Barros PR; Rodrigues D; Machado MR; Martins RB; Santos-Eichler RA; Benatti MN; de Sá KSG; Almado CEL; Castro ÍA; Pontelli MC; Serra L; Carneiro FS; Becari C; Louzada-Junior P; Oliveira RDR; Zamboni DS; Arruda E; Auxiliadora-Martins M; Giachini FRC; Bonato VLD; Zachara NE; Bomfim GF; Tostes RC Vascul Pharmacol; 2022 Feb; 142():106946. PubMed ID: 34838735 [TBL] [Abstract][Full Text] [Related]